Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

RAS antibody (AA 1-186)

This Mouse Monoclonal antibody specifically detects RAS in WB, ELISA, IF and ICC. It exhibits reactivity toward Human.
Catalog No. ABIN5776161

Quick Overview for RAS antibody (AA 1-186) (ABIN5776161)

Target

RAS

Reactivity

  • 17
  • 15
  • 15
  • 7
Human

Host

  • 15
  • 1
  • 1
Mouse

Clonality

  • 9
  • 8
Monoclonal

Conjugate

  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This RAS antibody is un-conjugated

Application

Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone

AT2F8
  • Binding Specificity

    • 1
    • 1
    • 1
    AA 1-186

    Immunogen

    Recombinant human KRAS (1-186aa) purified from E. coli

    Isotype

    IgG2b kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
  • Target

    RAS

    Alternative Name

    Ras

    Background

    All RAS protein family members belong to a class of protein called small GTPase, and are involved cellular signal transduction. RAS is 'switched on' by incoming signals, it subsequently switches on other proteins, which ultimately turn on genes involved in cell growth, differentiation and survival. Mutations in RAS genes can lead to the production of permanently activated RAS proteins. This can cause unintended and overactive signaling inside the cell, even in the absence of incoming signals. Because these signals result in cell growth and division, overactive RAS signaling can ultimately lead to cancer. The 3 Ras genes in humans (HRas, KRas, NRas) are the most common oncogenes in human cancer, mutations that permanently activate RAS are found in 20 % to 25 % of all human tumors and up to 90 % in certain types of cancer. RAS inhibitors are being studied as a treatment for cancer, and other diseases with RAS overexpression.

    NCBI Accession

    NP_203524
You are here:
Chat with us!